Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Oral JAK inhibitor for rheumatoid arthritis, eczema and alopecia areata. | Tablet that blocks inflammation signals for arthritis and colitis. |
| Body system | Joints & Immunity | Joints & Immunity |
| Drug class | JAK inhibitors | JAK inhibitors |
| Supply | Prescription only | Prescription only |
| Main uses | Rheumatoid arthritis, Atopic dermatitis (eczema), Alopecia areata, Hospitalised COVID-19 | Rheumatoid arthritis, Psoriatic arthritis, Ulcerative colitis, Ankylosing spondylitis |
| How it works | Calms immune signalling inside cells. | Blocks the relay inside immune cells that passes on inflammation signals. |
| Starts working | Weeks | — |
| Half-life | About 12 hours | About 3 hours |
| Typical adult dose | 4 mg once a day (2 mg if risk factors or after response). | 5 mg twice a day (10 mg twice a day for induction in ulcerative colitis). |
| Forms | Tablet | Tablet, Modified-release tablet, Oral solution |
| Common side effects | Upper respiratory infections, Raised cholesterol, Nausea, Cold sores | Cold-like infections, Headache, Diarrhoea, Raised cholesterol |
| Serious side effects | Serious infections, Blood clots, Heart attack and stroke, Cancers | Shingles, Blood clots, Heart attacks and cancer in at-risk groups, Serious infections |
| Don't take if | Active serious infection; Active TB; Pregnancy; Severe liver impairment | — |
| Alcohol | Best to limit. Alcohol may add to liver strain. | — |
| Pregnancy | Usually avoidedAvoid in pregnancy. | Usually avoidedNot recommended. |
| Breastfeeding | Usually avoidedAvoid. | — |
| In use since | — | 2012 |
| Brand names | United States: OlumiantUnited Kingdom: OlumiantIndia: Olumiant, Bariciti, Baricitinib (generic) | United States: XeljanzUnited Kingdom: XeljanzIndia: Tofacinix, Xeljanz |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | L04AA37 | — |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker